Dr William Paul Biddle, MD | |
Emile 42nd St, Omaha, NE 68198-2027 | |
(402) 559-8888 | |
(402) 559-3060 |
Full Name | Dr William Paul Biddle |
---|---|
Gender | Male |
Speciality | Cardiovascular Disease (cardiology) |
Experience | 40 Years |
Location | Emile 42nd St, Omaha, Nebraska |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1538273255 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0000X | Internal Medicine - Cardiovascular Disease | 18845 (Nebraska) | Secondary |
207RI0011X | Internal Medicine - Interventional Cardiology | 18845 (Nebraska) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
The Nebraska Medical Center | Omaha, NE | Hospital |
Crawford County Memorial Hospital | Denison, IA | Hospital |
Bellevue Medical Center | Bellevue, NE | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Unmc Physicians | 6002728391 | 1320 |
News Archive
Altheus Therapeutics, Inc., announced that it has completed enrollment for ZA201, a 6-week, double-blind, active-controlled Phase 2 clinical trial of the efficacy and safety of Zoenasa Rectal Gel in approximately 120 adult patients with left-sided, or distal, ulcerative colitis. Topline results are expected in to be available in March or early April.
A simple but revolutionary approach to early Alzheimer's diagnosis is being pioneered by researchers through an initiative that could pave the way for improved outcomes for individuals who develop the disease in the future.
A recent study by a multidisciplinary team of cardiologists and infectious disease specialists at Children's Hospital Colorado (Children's Colorado) found that pediatric patients suffering from Multisystem Inflammatory Syndrome (MIS-C) who received initial, intensified therapy consisting of intravenous immunoglobulin (IVIG) plus Infliximab had improved cardiac outcomes versus those who received IVIG alone.
Reaching a clinic in time to receive an early diagnosis for cancer - when the disease is most treatable - is a global problem. And now a team of Chinese researchers proposes a global solution: have a user-friendly diagnostic device travel to the patient, anywhere in the world.
BioVex Inc, a private biotechnology company developing new generation biologics for the treatment of cancer and prevention of infectious disease, announced today that the first subject had been dosed in the Phase 1 study of its live attenuated genital herpes vaccine, ImmunoVEXHSV2. The Phase 1 study is an open label ascending dose trial, assessing safety and immune response in healthy volunteers. The study is taking place in the UK at the Chelsea and Westminster Hospital in London and will involve up to 42 already identified subjects.
› Verified 7 days ago
Entity Name | Unmc Physicians |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1417912114 PECOS PAC ID: 6002728391 Enrollment ID: O20031104000664 |
News Archive
Altheus Therapeutics, Inc., announced that it has completed enrollment for ZA201, a 6-week, double-blind, active-controlled Phase 2 clinical trial of the efficacy and safety of Zoenasa Rectal Gel in approximately 120 adult patients with left-sided, or distal, ulcerative colitis. Topline results are expected in to be available in March or early April.
A simple but revolutionary approach to early Alzheimer's diagnosis is being pioneered by researchers through an initiative that could pave the way for improved outcomes for individuals who develop the disease in the future.
A recent study by a multidisciplinary team of cardiologists and infectious disease specialists at Children's Hospital Colorado (Children's Colorado) found that pediatric patients suffering from Multisystem Inflammatory Syndrome (MIS-C) who received initial, intensified therapy consisting of intravenous immunoglobulin (IVIG) plus Infliximab had improved cardiac outcomes versus those who received IVIG alone.
Reaching a clinic in time to receive an early diagnosis for cancer - when the disease is most treatable - is a global problem. And now a team of Chinese researchers proposes a global solution: have a user-friendly diagnostic device travel to the patient, anywhere in the world.
BioVex Inc, a private biotechnology company developing new generation biologics for the treatment of cancer and prevention of infectious disease, announced today that the first subject had been dosed in the Phase 1 study of its live attenuated genital herpes vaccine, ImmunoVEXHSV2. The Phase 1 study is an open label ascending dose trial, assessing safety and immune response in healthy volunteers. The study is taking place in the UK at the Chelsea and Westminster Hospital in London and will involve up to 42 already identified subjects.
› Verified 7 days ago
Entity Name | Franciscan Care Services Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1043224975 PECOS PAC ID: 4284624909 Enrollment ID: O20040514000822 |
News Archive
Altheus Therapeutics, Inc., announced that it has completed enrollment for ZA201, a 6-week, double-blind, active-controlled Phase 2 clinical trial of the efficacy and safety of Zoenasa Rectal Gel in approximately 120 adult patients with left-sided, or distal, ulcerative colitis. Topline results are expected in to be available in March or early April.
A simple but revolutionary approach to early Alzheimer's diagnosis is being pioneered by researchers through an initiative that could pave the way for improved outcomes for individuals who develop the disease in the future.
A recent study by a multidisciplinary team of cardiologists and infectious disease specialists at Children's Hospital Colorado (Children's Colorado) found that pediatric patients suffering from Multisystem Inflammatory Syndrome (MIS-C) who received initial, intensified therapy consisting of intravenous immunoglobulin (IVIG) plus Infliximab had improved cardiac outcomes versus those who received IVIG alone.
Reaching a clinic in time to receive an early diagnosis for cancer - when the disease is most treatable - is a global problem. And now a team of Chinese researchers proposes a global solution: have a user-friendly diagnostic device travel to the patient, anywhere in the world.
BioVex Inc, a private biotechnology company developing new generation biologics for the treatment of cancer and prevention of infectious disease, announced today that the first subject had been dosed in the Phase 1 study of its live attenuated genital herpes vaccine, ImmunoVEXHSV2. The Phase 1 study is an open label ascending dose trial, assessing safety and immune response in healthy volunteers. The study is taking place in the UK at the Chelsea and Westminster Hospital in London and will involve up to 42 already identified subjects.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Dr William Paul Biddle, MD 988102 Nebraska Medical Ctr, Omaha, NE 68198-8102 Ph: () - | Dr William Paul Biddle, MD Emile 42nd St, Omaha, NE 68198-2027 Ph: (402) 559-8888 |
News Archive
Altheus Therapeutics, Inc., announced that it has completed enrollment for ZA201, a 6-week, double-blind, active-controlled Phase 2 clinical trial of the efficacy and safety of Zoenasa Rectal Gel in approximately 120 adult patients with left-sided, or distal, ulcerative colitis. Topline results are expected in to be available in March or early April.
A simple but revolutionary approach to early Alzheimer's diagnosis is being pioneered by researchers through an initiative that could pave the way for improved outcomes for individuals who develop the disease in the future.
A recent study by a multidisciplinary team of cardiologists and infectious disease specialists at Children's Hospital Colorado (Children's Colorado) found that pediatric patients suffering from Multisystem Inflammatory Syndrome (MIS-C) who received initial, intensified therapy consisting of intravenous immunoglobulin (IVIG) plus Infliximab had improved cardiac outcomes versus those who received IVIG alone.
Reaching a clinic in time to receive an early diagnosis for cancer - when the disease is most treatable - is a global problem. And now a team of Chinese researchers proposes a global solution: have a user-friendly diagnostic device travel to the patient, anywhere in the world.
BioVex Inc, a private biotechnology company developing new generation biologics for the treatment of cancer and prevention of infectious disease, announced today that the first subject had been dosed in the Phase 1 study of its live attenuated genital herpes vaccine, ImmunoVEXHSV2. The Phase 1 study is an open label ascending dose trial, assessing safety and immune response in healthy volunteers. The study is taking place in the UK at the Chelsea and Westminster Hospital in London and will involve up to 42 already identified subjects.
› Verified 7 days ago
Dr. Marium Ilahi, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 7710 Mercy Rd, Suite 426, Omaha, NE 68124 Phone: 402-717-3636 Fax: 402-717-5050 | |
Dr. Vidhya Murukesan, M.B.,B.S Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 601 N 30th St, Creighton University - Gme, Omaha, NE 68131 Phone: 402-280-5250 | |
Matthew John Kapalis, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 7500 Mercy Rd, Omaha, NE 68124 Phone: 402-398-6255 Fax: 402-398-6255 | |
Abbie K Ray-deering, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 17500 Burke St, Omaha, NE 68118 Phone: 402-354-2360 Fax: 402-354-2440 | |
Dr. Elizabeth Rini Schnaubelt, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: Emile @ 42nd St, Omaha, NE 68198 Phone: 402-559-4015 Fax: 402-559-5581 | |
Sarah Kesterson, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 982055 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 402-559-7792 Fax: 402-559-9385 | |
Dr. Lauren C Licitra, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 42 Nd And Emile St, Omaha, NE 68198 Phone: 402-559-4000 |